Based on a survey of 200 executives at big (>$1 billion) pharma companies operating in the US, Accenture (New York) finds confirmation of some well-recognized trends—a move toward digital promotion and nonpersonal sales; establishing multichannel marketing programs; and increased capabilities […]
Read MoreSince the 1990s, Omnicare (Cincinnati) has been one of the leading pharmacy supply services to the long-term care (LTC) market. Starting in the mid-2000s, the company made a series of acquisitions and, in November 2010, unified them as the Omnicare […]
Read MoreFig. 2. Cognex’ In-Sight 2.0 device can read and decode multiple barcode formats, and is programmed to meet 21 CFR Part 11 record-keeping requirements. Credit: Cognex The pharma industry is turning a corner with the decade-long effort to establish item-level […]
Read MoreKantar Health, a leading global healthcare advisory and market research firm, brought together in 2009 four distinct companies from the life sciences industry—Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment—all rich in clinical and therapeutic knowledge, scientific expertise and commercial […]
Read MoreWhile R&D directors and healthcare managers puzzle through the evolving scene in pharmaceutical science and practice trends, the companies that provide real estate services to life sciences are doing the same—but with obvious differences in their approach. While patent applications, […]
Read MoreA comprehensive study of patients, pharmacists, physicians and payers, including polling of panels, focus groups and one-on-one interviews, paints a picture of the growing importance of copay cards in today’s healthcare system. Patients appreciate the cost savings (which is to […]
Read MorePharma 2020: From Vision to Decision is the title of this year’s analysis, from PricewaterhouseCoopers’ Pharmaceutical, Medical Device and Life Sciences Group. In wide-ranging commentary, PwC predicts that a new “golden era” of the biopharma industry could be coming, but […]
Read MoreA first-of-its-kind study, according to its sponsors, of preventable medication errors due to use of injected drugs, finds a billion-dollar problem in US healthcare. And while many of these errors (such as sepsis) result from poor treatment compliance, some can […]
Read MoreNon-adherence—not taking the drugs that have been prescribed by physicians, or not taking them as per their recommended regimen—is a longstanding, well-recognized problem in healthcare. Most recently, healthcare providers, spurred by provisions of the Affordable Care Act, now have incentives […]
Read MoreIn addition to these ‘core functions,’ plan managers are also charged with formulating risk pools; setting up reinsurance;and enabling data communications between plans, states and the federal government The Affordable Care Act—“Obamacare”—primarily affects how health insurance is organized and funded; […]
Read More
